We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.19B
AUM Growth
+$379M
Cap. Flow
+$591M
Cap. Flow %
26.94%
Top 10 Hldgs %
22.42%
Holding
516
New
175
Increased
81
Reduced
53
Closed
163

Top Sells

Rank Stock Value
1
WDC icon
Western Digital
WDC
+$30.5M
2
WMT icon
Walmart Inc
WMT
+$29.1M
3
LRCX icon
Lam Research
LRCX
+$19.5M
4
AOS icon
A.O. Smith
AOS
+$15.8M
5
GM icon
General Motors
GM
+$14.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.98%
2 Technology 8%
3 Industrials 7.08%
4 Consumer Staples 5.1%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGV icon
301
iShares Expanded Tech-Software Sector ETF
IGV
$14.4B
$366K 0.02%
+5,305
New +$364K
ACAD icon
302
PUT
Acadia Pharmaceuticals
ACAD
$4.65B
$363K 0.02%
+15,000
New +$363K
DBD
303
DELISTED
Diebold Nixdorf Incorporated
DBD
$353K 0.02%
+52,500
New +$449K
CHWY icon
304
Chewy
CHWY
$9.87B
$347K 0.02%
+8,498
New +$386K
LIT icon
305
Global X Lithium & Battery Tech ETF
LIT
$1.55B
$346K 0.02%
4,500
-58,328
-93% -$4.46M
CTIC
306
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$333K 0.02%
+71,343
New +$213K
RXRAU
307
DELISTED
RXR Acquisition Corp. Units
RXRAU
$311K 0.01%
31,559
XPH icon
308
State Street SPDR S&P Pharmaceuticals ETF
XPH
$503M
$297K 0.01%
+6,557
New +$288K
XLE icon
309
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$287K 0.01%
7,500
-159,348
-96% -$5.52M
CYPH
310
Cypherpunk Technologies Inc
CYPH
$73.5M
$284K 0.01%
16,200
-37,800
-70% -$808K
PARA
311
DELISTED
Paramount Global Class B
PARA
$284K 0.01%
+7,507
New +$256K
NVDA icon
312
NVIDIA
NVDA
$5.13T
$262K 0.01%
9,590
-87,590
-90% -$2.2M
XYZ
313
Block Inc
XYZ
$50.4B
$252K 0.01%
+1,860
New +$225K
MREO
314
Mereo BioPharma
MREO
$51.4M
$243K 0.01%
217,051
+149,550
+222% +$193K
SHOP icon
315
Shopify
SHOP
$160B
$240K 0.01%
3,550
+420
+13% +$34.5K
X
316
DELISTED
US Steel
X
$227K 0.01%
+6,007
New +$163K
RIVN icon
317
CALL
Rivian
RIVN
$22.8B
$226K 0.01%
+4,500
New +$274K
XME icon
318
State Street SPDR S&P Metals & Mining ETF
XME
$4.12B
$221K 0.01%
+3,606
New +$184K
SOFI icon
319
PUT
SoFi Technologies
SOFI
$24.1B
$213K 0.01%
+22,500
New +$258K
HNRG icon
320
Hallador Energy
HNRG
$713M
$210K 0.01%
+60,000
New +$188K
RZLT icon
321
Rezolute
RZLT
$479M
$183K 0.01%
54,000
-148,500
-73% -$572K
TARS icon
322
Tarsus Pharmaceuticals
TARS
$2.67B
$177K 0.01%
+10,544
New +$196K
VINC
323
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$172K 0.01%
2,155
BBBY
324
CALL
Bed Bath & Beyond
BBBY
$530M
$132K 0.01%
+3,300
New +$147K
OPAL icon
325
CALL
OPAL Fuels
OPAL
$72.9M
$102K ﹤0.01%
74,900

Similar funds

J. Goldman & Co's Q1 2022 Portfolio in Review

As of Q1 2022, J. Goldman & Co held 516 positions worth $2.19B, up 21% from $1.81B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

J. Goldman & Co deployed $591M of net new capital in Q1 2022, opening 175 new positions and adding to 81 existing holdings. Its largest new stake was Cisco: 803,597 shares worth $44.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Micron Technology, an estimated $12.4M trimmed.

  • J. Goldman & Co's largest Q1 2022 buy was Cisco: 803,597 shares worth $44.8M.
  • J. Goldman & Co added most to Bath & Body Works in Q1 2022, an estimated $54.2M increase.
  • J. Goldman & Co's biggest Q1 2022 reduction was Micron Technology, cutting an estimated $12.4M.
  • J. Goldman & Co fully exited Western Digital in Q1 2022, selling an estimated $30.5M.
  • J. Goldman & Co's ten largest holdings make up 22% of its $2.19B portfolio in Q1 2022.
  • J. Goldman & Co opened 175 new positions and closed 163 in Q1 2022.
  • J. Goldman & Co's portfolio value rose 21% quarter-over-quarter to $2.19B.

Based on J. Goldman & Co's 13F filing for Q1 2022, filed 16 May 2022.